Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$56.27 - $73.77 $36,575 - $47,950
-650 Reduced 17.38%
3,090 $213,000
Q4 2023

Jan 24, 2024

BUY
$59.06 - $75.72 $220,884 - $283,192
3,740 New
3,740 $276,000
Q1 2022

Apr 27, 2022

SELL
$57.56 - $82.54 $58,423 - $83,778
-1,015 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$72.5 - $100.68 $73,587 - $102,190
1,015 New
1,015 $78,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.